Uesaka Katsuhiko 上坂克彦

… Alternative Names

Researcher Number	20283434
Affiliation (Current)	2022: 静岡県立静岡がんセンター(研究所), その他部局等, 研究員
Affiliation (based on the past Project Information) *help	2021: 静岡県立静岡がんセンター(研究所), その他部局等, 研究員 2017 – 2019: 静岡県立静岡がんセンター(研究所), その他部局等, 研究員 2001: 名古屋大学, 医学部・附属病院, 助手 1997 – 2000: 名古屋大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Digestive surgery / Digestive surgery / Basic Section 55020:Digestive surgery-related Except Principal Investigator Digestive surgery / Basic Section 55020:Digestive surgery-related
Keywords	Principal Investigator ICAM-1 / 膵癌 / バイオマーカー / 腸管うっ滞 / 腸内細菌 / 常在菌 / 炎症 / 接着分子 / 血管内皮 / intestinal stasis … More Except Principal Investigator 肝不全 / SIRS / 術後肝不全 / 肝微小循環 / Ipsilateral approach / 肝再生 / Apoptosis / Liver regeneration / TNF-α / 敗血症 / 網内系機能 / 多臓器不全 / 細菌感染 / 酸化窒素 / NO合成酵素 / 出血性ショック再蘇生モデル / 大量肝切除モデル / Nitric Oxide / 肝網内系機能 / 手術侵襲 / サイトカイン / 出血性ショック / Kupper細胞 / インターロイキン / sepsis / hepatic failure / reticuloendothelial function / multiple organ failure / bacterial infection / nitric oxide / NO synthetase / 経皮経肝門脈枝塞栓術 / 三区域門脈枝塞栓術 / 門脈・肝動脈塞栓術 / 門脈血流速度 / 超音波Doppler検査 / 肝門部胆肝癌 / 胆嚢癌 / 肝切除術 / Percutaneous transhepatic protal vein embolization / Trisegment portal vein embolization / Portal plus arterial embolization / Portal blood flow velocity / Doppler ultrasound / 虚血再灌流障害 / ブレコンディショニング / 高脂血症 / 白血球 / クッパー細胞 / 接着分子 / プレコンディショニング / 虚血再灌流傷害 / 肝細胞傷害 / SWOP / Ischemia reperfusion injury / Preconditioning / Liver failure / Hypercholesterolemia / Leukocyte / Kupffer cell / Adhesion molecule / 門脈枝塞栓術 / 門脈血流 / インターロイキン-6 / 血管内皮 / ストレッチストレス / NFκB / 門脈内皮ストレッチ / 門脈内径 / Portal vein embolization / Portal blood flow / Interleukin-6 / Endothelial cell / Stretch stress / NF κ B / 肝 / 胆管 / 萎縮 / 肥大 / エタノール / 胆管能動的閉鎖法 / 残肝体積増大法 / 胆管内無水エタノール注入 / liver / bile duct / atrophy / hypertrophy / ethanol / 肝細胞癌 / 同一がん遺伝子内複数変異 / 免疫関連遺伝子 / 次世代シークエンサー Less

Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancerPrincipal Investigator
- Principal Investigator
  
  上坂克彦
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Shizuoka Cancer Center Research Institute
Establishment of treatment strategy based on the clinical significance of multiple mutations in individual genes in hepatocellular carcinoma
- Principal Investigator
  
  岡村行泰
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Nihon University
Establishment of tailor-made adjuvant therapy for pancreatic cancer with biomarker using JASPAC 01 samplesPrincipal Investigator
- Principal Investigator
  
  Uesaka Katsuhiko
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Shizuoka Cancer Center Research Institute
Clinical and experimental study of regeneration of nonembolized lobe after portal vein embolization
- Principal Investigator
  
  NAGINO Masato
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University
An experimental and clinical study of selective intrahepatic biliary ablatron with absolute ethanol
- Principal Investigator
  
  KAMIYA Junichi
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University
Experimental study on effect of preconditioning to hepatic ischemia/reperfusion injury.
- Principal Investigator
  
  NAGINO Masato
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University
Study of molecular pathology for intestinal stasis-associated bowel diseasesPrincipal Investigator
- Principal Investigator
  
  UESAKA Katsuhiko
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University
安全な広範肝切除を目的とした門脈枝塞栓術の基礎的および臨床的研究
- Principal Investigator
  
  NAGINO Masato
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University
Basic and clinical studies asociated with hepatic reticulo endothelial system after major surgery
- Principal Investigator
  
  NIMURA Yuji
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Nagoya University

All 2019 2018

All Journal Article Presentation

[Journal Article] Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy2019
- Author(s)
  Okamura Y, Yasukawa S, Narimatsu H, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Yamakita K, Takahashi A, Kainuma O, Hishinuma S, Yamaguchi R, Nagino M, Hirano S, Yanagisawa A, Mori K, Uesaka K
- Journal Title
  
  Cancer Science
  
  Volume: 111 Pages: 548-560
- DOI
  10.1111/cas.14258
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04288
[Presentation] High human equilibrative nucleoside transporter-1 (hENT1) expression is a significant unfavorable prognostic factor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy2019
- Author(s)
  Okamura Y, Yasukawa S, Narimatsu H, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Uesaka K
- Organizer
  日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04288
[Presentation] The hENT1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial2019
- Author(s)
  Okamura Y, Yasukawa S, Narimatsu H, Evans A, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Yamakita K, Sakamoto H, Takayama W, Yamaguchi R, Yanagisawa A, Neoptolemos J, Uesaka K
- Organizer
  日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04288
[Presentation] DPD and hENT1 are not predictive in patients with resected pancreatic cancer treated with adjuvant S-1 or gemcitabine chemotherapy: Collaborative study of the JASPAC 01 trial.2019
- Author(s)
  Y. Okamura, S. Yasukawa, K. Mori, N. Boku, A. Fukutomi, M. Konishi, S. Morinaga, H Toyama, Y. Kaneoka, Y. Shimizu, S. Nakamori, N. Sata, O. Kainuma, Y. Kitano, H. Sakamoto, R. Yamaguchi, S. Hishinuma, S. Hirano A. Yanagisawa, K. Uesaka
- Organizer
  Society of Surgical Oncology 72nd Annual Cancer Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04288
[Presentation] The human equilibrative nucleoside transporter1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial2019
- Author(s)
  Okamura Y, Yasukawa S, Narimatsu H, Evans A, Boku N, Fukutomi A, Konishi M, Morinaga S, Toyama H, Kaneoka Y, Shimizu Y, Nakamori S, Sata N, Yamakita K, Sakamoto H, Takayama W, Yamaguchi R, Yanagisawa A, Neoptolemos J, Uesaka K
- Organizer
  51st European Pancreatic Club
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04288
[Presentation] Dihydropyrimidine dehydrogenase (DPD) and human equilibrative nucleoside transporter-1 (hENT1) are not predictive in patients with resected pancreatic cancer treated with adjuvant S-1 or gemcitabine chemotherapy: Collaborative study of the JASPAC 01 trial.2018
- Author(s)
  Yukiyasu Okamura, Katsuhiko Uesaka
- Organizer
  ESMO 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04288

1. KIMIYA Junichi (70194975)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
2. NIMURA Yuji (80126888)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
3. NAGINO Masato (20237564)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
4. ODA Kouji (30311715)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
5. YUASA Norihiro (00303610)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
6. 岡村行泰 (10704489)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
7. KANAI Michio (50242871)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. MIYACHI Masahiko (80242874)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. ARAI Toshiyuki (80335041)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. 大島啓一 (10399587)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. KONDO Satoshi (30215454)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. SANO Tsuyoshi (60303632)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. NISHIO Hideki (30345897)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 杉浦禎一 (10402588)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 伊藤貴明 (30765938)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Uesaka Katsuhiko 上坂 克彦

上坂 克彦 ウエサカ カツヒコ

MIYACHI Katsuhiko 上坂 克彦

Research Projects

Research Products

Co-Researchers

Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of treatment strategy based on the clinical significance of multiple mutations in individual genes in hepatocellular carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of tailor-made adjuvant therapy for pancreatic cancer with biomarker using JASPAC 01 samplesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical and experimental study of regeneration of nonembolized lobe after portal vein embolization

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

An experimental and clinical study of selective intrahepatic biliary ablatron with absolute ethanol

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Experimental study on effect of preconditioning to hepatic ischemia/reperfusion injury.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of molecular pathology for intestinal stasis-associated bowel diseasesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

安全な広範肝切除を目的とした門脈枝塞栓術の基礎的および臨床的研究

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic and clinical studies asociated with hepatic reticulo endothelial system after major surgery

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] High human equilibrative nucleoside transporter-1 (hENT1) expression is a significant unfavorable prognostic factor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy2019

Author(s)

Organizer

Data Source

[Presentation] The hENT1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial2019

Author(s)

Organizer

Data Source

[Presentation] DPD and hENT1 are not predictive in patients with resected pancreatic cancer treated with adjuvant S-1 or gemcitabine chemotherapy: Collaborative study of the JASPAC 01 trial.2019

Author(s)

Organizer

Data Source

[Presentation] The human equilibrative nucleoside transporter1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial2019

Author(s)

Organizer

Uesaka Katsuhiko 上坂克彦

上坂克彦ウエサカカツヒコ

MIYACHI Katsuhiko 上坂克彦